Regulation of soluble fms-like tyrosine kinase-1 production in response to placental ischemia/hypoxia: Role of angiotensin II

Physiological Reports

Volumn 3, Issue 2, 2015, Pages

  Murphy, Sydney R ^a   Cockrell, Kathy ^b  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Angiotension II; Placental ischemia; Preeclampsia; Reduced uterine perfusion pressure; sFlt 1

Indexed keywords

ANGIOTENSIN II; LOSARTAN; PROTEIN TYROSINE KINASE; SOLUBLE FMS LIKE TYROSINE 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERTENSION; HYPOXIA; ISCHEMIA; NONHUMAN; PERFUSION PRESSURE; PLACENTAL ISCHEMIA; PREECLAMPSIA; PREGNANCY; RAT;

EID: 85006058934     PISSN: None     EISSN: 2051817X     Source Type: Journal    
DOI: 10.14814/phy2.12310     Document Type: Article

References (37)

1. Ahmad, S., and A. Ahmed. 2004. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circ. Res. 95:884–891.
2. Ain, R., T. Konno, L. N. Canham, and M. J. Soares. 2006. Phenotypic analysis of the rat placenta. Methods Mol. Med. 121:295–313.
3. Anton, L., D. C. Merrill, L. A. Neves, K. Stovall, P. E. Gallagher, D. I. Diz, C. Moorefield, et al. 2008. Activation of local chorionic villi angiotensin II levels but not angiotensin (1-7) in preeclampsia. Hypertension 51:1066–1072.
4. Brown, M. A., J. Wang, and J. A. Whitworth. 1997. The reninangiotensin- aldosterone system in pre-eclampsia. Clin. Exp. Hypertens. 19:713–726.
5. Caniggia, I., J. Winter, S. J. Lye, and M. Post. 2000. Oxygen and placental development during the first trimester: implications for the pathophysiology of pre-eclampsia. Placenta 21(Suppl A):S25–S30.
6. Dechend, R., V. Homuth, G. Wallukat, D. N. Muller, M. Krause, J. Dudenhausen, H. Haller, et al. 2006. Agonistic antibodies directed at the angiotensin II, AT1 receptor in preeclampsia. J. Soc. Gynecol. Investig. 13:79–86.
7. Gilbert, J. S., S. A. Babcock, and J. P. Granger. 2007. Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression. Hypertension 50:1142–1147.
8. Granger, J. P., B. B. LaMarca, K. Cockrell, M. Sedeek, C. Balzi, D. Chandler, and W. Bennett. 2006. Reduced uterine perfusion pressure (RUPP) model for studying cardiovascular-renal dysfunction in response to placental ischemia. Methods Mol. Med. 122:383–392.
9. Herse, F., R. Dechend, N. K. Harsem, G. Wallukat, J. Janke, F. Qadri, L. Hering, et al. 2007. Dysregulation of the circulating and tissue-based renin-angiotensin system in preeclampsia. Hypertension 49:604–611.
10. Herse, F., A. C. Staff, L. Hering, D. N. Muller, F. C. Luft, and R. Dechend. 2008. AT1-receptor autoantibodies and uteroplacental RAS in pregnancy and pre-eclampsia. J. Mol. Med. 86:697–703.
11. Heydarian, M., T. McCaffrey, L. Florea, Z. Yang, M. M. Ross, W. Zhou, and S. E. Maynard. 2009. Novel splice variants of sFlt1 are upregulated in preeclampsia. Placenta 30:250–255.
12. Irani, R. A., and Y. Xia. 2008. The functional role of the renin-angiotensin system in pregnancy and preeclampsia. Placenta 29:763–771.
13. Karumanchi, S. A., and F. H. Epstein. 2007. Placental ischemia and soluble fms-like tyrosine kinase 1: cause or consequence of preeclampsia? Kidney Int. 71:959–961.
14. Karumanchi, S. A., and M. D. Lindheimer. 2008. Preeclampsia pathogenesis: “triple a rating”-autoantibodies and antiangiogenic factors. Hypertension 51:991–992.
15. Konno, T., L. A. Rempel, J. A. Arroyo, and M. J. Soares. 2007. Pregnancy in the brown Norway rat: a model for investigating the genetics of placentation. Biol. Reprod. 76:709–718.
16. Lam, C., K. H. Lim, and S. A. Karumanchi. 2005. Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia. Hypertension 46:1077–1085.
17. LaMarca, B., M. Parrish, L. F. Ray, S. R. Murphy, L. Roberts, P. Glover, G. Wallukat, et al. 2009. Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1. Hypertension 54:905–909.
18. Levine, R. J., S. E. Maynard, C. Qian, K. H. Lim, L. J. England, K. F. Yu, E. F. Schisterman, et al. 2004. Circulating angiogenic factors and the risk of preeclampsia. N. Engl. J. Med. 350:672–683.
19. Makris, A., C. Thornton, J. Thompson, S. Thomson, R. Martin, R. Ogle, R. Waugh, et al. 2007. Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1. Kidney Int. 71:977–984.
20. Maynard, S. E., J. Y. Min, J. Merchan, K. H. Lim, J. Li, S. Mondal, T. A. Libermann, et al. 2003. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest. 111:649–658.
21. Merrill, D. C., M. Karoly, K. Chen, C. M. Ferrario, and K. B. Brosnihan. 2002. Angiotensin-(1–7) in normal and preeclamptic pregnancy. Endocrine 18:239–245.
22. Nagamatsu, T., T. Fujii, M. Kusumi, L. Zou, T. Yamashita, Y. Osuga, M. Momoeda, et al. 2004. Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia. Endocrinology 145:4838–4845.
23. Nevo, O., N. Soleymanlou, Y. Wu, J. Xu, J. Kingdom, A. Many, S. Zamudio, et al. 2006. Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1. Am. J. Physiol. Regul. Integr. Comp. Physiol. 291:R1085–R1093.
24. Nielsen, A. H., K. H. Schauser, and K. Poulsen. 2000. Current topic: the uteroplacental renin-angiotensin system. Placenta 21:468–477.
25. Parrish, M. R., S. R. Murphy, S. Rutland, K. Wallace, K. Wenzel, G. Wallukat, S. Keiser, et al. 2010. The effect of immune factors, tumor necrosis factor-alpha, and agonistic autoantibodies to the angiotensin II type I receptor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancy. Am. J. Hypertens. 23:911–916.
26. Rajakumar, A., H. M. Michael, P. A. Rajakumar, E. Shibata, C. A. Hubel, S. A. Karumanchi, R. Thadhani, et al. 2005. Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women. Placenta 26:563–573.
27. Rajakumar, A., R. W. Powers, C. A. Hubel, E. Shibata, F. von Versen-Hoynck, D. Plymire, and A. Jeyabalan. 2009. Novel soluble Flt-1 isoforms in plasma and cultured placental explants from normotensive pregnant and preeclamptic women. Placenta 30:25–34.
28. Roberts, J. M. 2000. Preeclampsia: what we know and what we do not know. Semin. Perinatol. 24:24–28.
29. Roberts, J. M., R. N. Taylor, T. J. Musci, G. M. Rodgers, C. A. Hubel, and M. K. McLaughlin. 1989. Preeclampsia: an endothelial cell disorder. Am. J. Obstet. Gynecol. 161: 1200–1204.
30. Shah, D. M. 2005. Role of the renin-angiotensin system in the pathogenesis of preeclampsia. Am. J. Physiol. Renal. Physiol. 288:F614–F625.
31. Sholook, M. M., J. S. Gilbert, M. H. Sedeek, M. Huang, R. L. Hester, and J. P. Granger. 2007. Systemic hemodynamic and regional blood flow changes in response to chronic reductions in uterine perfusion pressure in pregnant rats. Am. J. Physiol. Heart Circ. Physiol. 293: H2080–H2084.
32. Skinner, S. L., E. R. Lumbers, and E. M. Symonds. 1972. Analysis of changes in the renin-angiotensin system during pregnancy. Clin. Sci. 42:479–488.
33. Tsatsaris, V., F. Goffin, C. Munaut, J. F. Brichant, M. R. Pignon, A. Noel, J. P. Schaaps, et al. 2003. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences. J. Clin. Endocrinol. Metab. 88:5555–5563.
34. Wallukat, G., V. Homuth, T. Fischer, C. Lindschau, B. Horstkamp, A. Jupner, E. Baur, et al. 1999. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J. Clin. Invest. 103:945–952.
35. Wang, A., S. Rana, and S. A. Karumanchi. 2009. Preeclampsia: the role of angiogenic factors in its pathogenesis. Physiology (Bethesda). 24:147–158.
36. Zhou, C. C., S. Ahmad, T. Mi, S. Abbasi, L. Xia, M. C. Day, S. M. Ramin, et al. 2008. Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling. Hypertension 51:1010–1019.
37. Zhou, C. C., S. Ahmad, T. Mi, L. Xia, S. Abbasi, P. W. Hewett, C. Sun, et al. 2007. Angiotensin II induces soluble fms-Like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy. Circ. Res. 100:88–95.